{
    "clinical_study": {
        "@rank": "163317", 
        "acronym": "NSAI vs NM", 
        "arm_group": [
            {
                "arm_group_label": "Intravenous NSAI", 
                "arm_group_type": "Active Comparator", 
                "description": "patients received 100 mg of ketoprofen (NSAID) by IV root  and in parallel 3 nebulisation of serum saline (SS) over 30 minutes."
            }, 
            {
                "arm_group_label": "Nebulised Morphine", 
                "arm_group_type": "Experimental", 
                "description": "patients received 3 nebulisation of morphine (5 mg each) and in parallel 50 ml of SS by IV root over 30 minutes."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the investigators  study was to evaluate the feasibility, efficacy and safety of\n      nebulized morphine compared with non-steroidal anti-inflammatory (NSAI)intravenously in the\n      management of renal colic.\n\n      Determine the need for systematic outpatient prescription of NSAI."
        }, 
        "brief_title": "IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Renal Colic", 
        "condition_browse": {
            "mesh_term": [
                "Renal Colic", 
                "Colic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Renal colic are a frequent cause of consultation in the emergency departement (ED).\n\n      They count for approximatively 20% of patients presenting to the ED with severe acute onset\n      abdominal pain.\n\n      For acute treatment of renal colics (RC), guidelines recommend the use of intravenous (IV)\n      non-steroidal anti-inflammatory (NSAI) drugs in association with antalgics like Paracetamol\n      or Morphine.\n\n      But the NSAID present many inconvenient and cannot be used in some type of patients; that's\n      why the investigators investigated the use of other drugs, such as nebulised morphine, in\n      the ED treatment of renal colics.\n\n      the NM has the adequacy of being quickest, more practical to use and more tolerated than the\n      IV NSAID.\n\n      In this study, the investigators aim to assess the feasibility, efficacity and safety of\n      nebulised morphine compared to intravenous NSAID in the treatment of RC."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Over 16 years old\n\n          -  Consenting to participate in the study\n\n          -  Diagnosis of renal colic matching flank pain / lumbar fossa sided with dipstick and /\n             or imaging confirmed the diagnosis\n\n          -  VAS> 50% at consultation\n\n        Exclusion Criteria:\n\n          -  Inability to assess pain VAS;\n\n          -  Pregnant or lactating woman;\n\n          -  Recognized renal disease (glomerular filtration rate <60ml/kg/1.73m2);\n\n          -  Known hepatic insufficiency;\n\n          -  Known or suspected allergy to NSAIDs, morphine\n\n          -  Peptic ulcer known;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02156596", 
            "org_study_id": "NSAI vs Morphine"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intravenous NSAI", 
                "description": "100 mg of ketoprofen in 50 ml volume given in 30 minutes by IV root", 
                "intervention_name": "IV NSAI", 
                "intervention_type": "Drug", 
                "other_name": "ketoprofen IV"
            }, 
            {
                "arm_group_label": "Nebulised Morphine", 
                "description": "3 nebulisations of 5 mg morphine chlorhydrate each given over 30 minutes (10 minutes per nebulisation)", 
                "intervention_name": "NM", 
                "intervention_type": "Drug", 
                "other_name": "morphine"
            }, 
            {
                "arm_group_label": "Nebulised Morphine", 
                "description": "50 ml of SS is given by IV root over 30 minutes", 
                "intervention_name": "IV Serum Saline", 
                "intervention_type": "Drug", 
                "other_name": "serum saline"
            }, 
            {
                "arm_group_label": "Intravenous NSAI", 
                "description": "3 nebulisations of 5ml SS each are given over 30 minutes", 
                "intervention_name": "Nebulised Serum Saline", 
                "intervention_type": "Drug", 
                "other_name": "serum saline"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Inflammatory Agents, Non-Steroidal", 
                "Ketoprofen", 
                "Morphine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "renal colic", 
            "nebulised morphine", 
            "Intravenous NSAID"
        ], 
        "lastchanged_date": "June 4, 2014", 
        "link": {
            "description": "official department site", 
            "url": "http://www.urgencemonastir.com"
        }, 
        "location": {
            "contact": {
                "email": "semir.nouira@rns.tn", 
                "last_name": "SEMIR NOUIRA, PHD", 
                "phone": "73106000"
            }, 
            "facility": {
                "address": {
                    "city": "Monastir", 
                    "country": "Tunisia", 
                    "zip": "5000"
                }, 
                "name": "Hospital of Fattouma Bourguiba"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Tunisia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Intravenous Treatment With NSAIDs Versus Nebulized Morphine Analgesia for First-line Renal Colic: Randomized Controlled Double-blind Single-center Study.", 
        "overall_contact": {
            "email": "semir.nouira@rns.tn", 
            "last_name": "Semir NOUIRA, Phd", 
            "phone": "73106000", 
            "phone_ext": "+216"
        }, 
        "overall_official": {
            "affiliation": "University of Monastir", 
            "last_name": "Nouira Semir, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Tunisia: Ministry of Public Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The effectiveness of treatment is defined by a decrease in the intensity of pain corresponding to a decrease of the VAS  above 50% at 60 minutes compared to baseline.", 
            "measure": "efficacity: VAS pain reduction", 
            "safety_issue": "No", 
            "time_frame": "5, 15, 30, 45 and 60 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02156596"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Monastir", 
            "investigator_full_name": "Nouira", 
            "investigator_title": "Intravenous treatment with NSAI versus nebulized morphine analgesia for first-line renal colic: randomized controlled double-blind single-center study.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "the feasibility is assessed by comparing the number of patients accepting the protocol to the total number of patients consulting for RC; and the number of patients that actually completed the protocol course (if above 50%, the protocol is considered feasable).", 
                "measure": "feasibility of the study: number of patients accepting the adhesion to protocol", 
                "safety_issue": "No", 
                "time_frame": "at base line and at 60 minutes"
            }, 
            {
                "description": "the safety of treatment is evaluated by the occurence of side effects at any time of the protocol.\nonly major side effects (repeated vomiting, untolerated dizziness, conscience troubles, dyspnea and allergic reaction) are admitted to stop the protocol.", 
                "measure": "safety: side effects of treatment", 
                "safety_issue": "No", 
                "time_frame": "5, 15, 30, 45 and 60 minutes"
            }
        ], 
        "source": "University of Monastir", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Monastir", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}